Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : SYNSORB (T.SYB)(SYBBF) CURE FOR CANCER? -- Ignore unavailable to you. Want to Upgrade?

To: Jim Oravetz who wrote (108)	5/25/2000 9:01:00 PM
From: Jim Oravetz	Read Replies (1) \| Respond to of 164

CALGARY (Dow Jones)--Synsorb Biotech Inc. (SYBB, news, msgs) said it has received Canadian government approval to ship its SYNSORB Pk treatment to an outbreak of E-coli bacteria in Ontario. In a press release, Synsorb said the shipments of emergency supplies will be sent to hospitals in the area of Walkerton, Ont. Five people have died and 10 are in critical condition after being infected with the bacteria in Walkerton, a southern Ontario town of about 5,000 residents. Synsorb said there is currently no available therapy for patients suffering from E-Coli infections. The company said SYNSORB Pk is a drug designed to prevent "serious complications associated with verotoxigenic E. coli infections." It said the drug has been granted Fast Track Product designation by the U.S. Food and Drug Administration. Jim